Published date: 7 January 2020

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 5 November 2019

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region

Value of contract

£4,844,000

Procurement reference

tender_219286/826226

Published date

7 January 2020

Closing date

5 November 2019

Contract start date

1 January 2020

Contract end date

31 December 2020

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National Framework Agreement for the supply of Lanadelumab. The framework agreement will
commence on 1.1.2020 for a period of 12 months, with options to extend for a further 36 months.

More information

Previous notice about this procurement

NHS National Framework Agreement for the supply of Lanadelumab

  • Opportunity
  • Published 3 October 2019

Attachments

Award information

Awarded date

18 December 2019

Contract start date

1 January 2020

Contract end date

31 December 2020

Total value of contract

£4,844,000

This contract was awarded to 1 supplier.

Shire Pharmaceuticals Ltd

Address

1 Kingdom Street, London, W2 6BD

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

philip.grieve@nhs.net